Carcinoma of the Pancreas and Selectron Brachytherapy

Carcinoma of the pancreas is now the fourth most common malignancy in many parts of the world. It is the major neoplasm in the hepato-biliary system which presents frequently as inoperable. It responds poorly to tele-radiotherapy and even bypass surgery gives the patient a very short time of relief. A search of the literature reveals the present dismal progress, even though the resection rate is rising and the operative mortality falling, results are still poor. Trede (1985) quotes resection as 21.3% of whom 28% survive 5 years for adeno carcinoma of the head of the pancreas. The resection rate of periampullary carcinoma is steady at 73% with a 50%